English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

While the pathophysiology underlying the COVID-19 infection remainsincompletely understood, there is growing evidence to indicate that it isclosely correlated to hypercoagulation among severely ill patients. Doctors maychoose for use anti-coagulation doses to treat the patients at intensive careunits. A rapid, easy, and low-cost solution to monitor the coagulation statusat the point-of-care may help with treatment by enabling the administration ofcontrolled doses of medication to patients and to understand the disease'sunderlying pathophysiology. Thromboelastography, the clinical standard isaccurate; it suffers from limited portability and low sensitivity whenminiaturized to handheld form factor. In the article, we summarize researchhelping to advance towards an integrated optofluidic device combiningmicrofluidics and photonic sensor technology. Microfluidics are used to performblood pre-processing, and a photonic sensor measures blood coagulation statusin real-time readout on the device itself. These techniques make it portableand scalable, potentially serving as technology foundation for the developmentof a disposable sensor for point-of-care diagnostics in COVID-19 patients andcoagulopathy in general.

Integrated Optofluidic Sensor for Coagulation Risk Monitoring in COVID-19 Patients at Point-of-Care